MA26854A1 - NON-PEPTIDE TACHYKININE RECEPTOR ANTAGONISTS - Google Patents
NON-PEPTIDE TACHYKININE RECEPTOR ANTAGONISTSInfo
- Publication number
- MA26854A1 MA26854A1 MA26689A MA26689A MA26854A1 MA 26854 A1 MA26854 A1 MA 26854A1 MA 26689 A MA26689 A MA 26689A MA 26689 A MA26689 A MA 26689A MA 26854 A1 MA26854 A1 MA 26854A1
- Authority
- MA
- Morocco
- Prior art keywords
- tachykinine
- peptide
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17154099P | 1999-12-22 | 1999-12-22 | |
| EP00103665A EP1127875A1 (en) | 2000-02-22 | 2000-02-22 | Process for the preparation of alpha-dimethylaminomethyl-tryptophan methyl ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26854A1 true MA26854A1 (en) | 2004-12-20 |
Family
ID=26070578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA26689A MA26854A1 (en) | 1999-12-22 | 2002-06-14 | NON-PEPTIDE TACHYKININE RECEPTOR ANTAGONISTS |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1244653A1 (en) |
| JP (1) | JP2003518111A (en) |
| KR (1) | KR20020062364A (en) |
| CN (1) | CN1413206A (en) |
| AP (1) | AP2002002556A0 (en) |
| AU (1) | AU2370801A (en) |
| BG (1) | BG106804A (en) |
| BR (1) | BR0016626A (en) |
| CA (1) | CA2399584A1 (en) |
| IL (1) | IL150203A0 (en) |
| IS (1) | IS6395A (en) |
| MA (1) | MA26854A1 (en) |
| MX (1) | MXPA02006282A (en) |
| NO (1) | NO20022942L (en) |
| OA (1) | OA12129A (en) |
| PL (1) | PL357650A1 (en) |
| SK (1) | SK8862002A3 (en) |
| WO (1) | WO2001046176A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0655055T3 (en) * | 1992-08-13 | 2001-01-02 | Warner Lambert Co | tachykinin antagonists |
| JP2002533338A (en) * | 1998-12-18 | 2002-10-08 | ワーナー−ランバート・カンパニー | Non-peptide NK1 receptor antagonist |
-
2000
- 2000-12-21 EP EP00987477A patent/EP1244653A1/en not_active Withdrawn
- 2000-12-21 OA OA1200200196A patent/OA12129A/en unknown
- 2000-12-21 MX MXPA02006282A patent/MXPA02006282A/en unknown
- 2000-12-21 JP JP2001547086A patent/JP2003518111A/en active Pending
- 2000-12-21 WO PCT/EP2000/013349 patent/WO2001046176A2/en active Search and Examination
- 2000-12-21 BR BR0016626-0A patent/BR0016626A/en not_active Application Discontinuation
- 2000-12-21 SK SK886-2002A patent/SK8862002A3/en unknown
- 2000-12-21 CN CN00817549A patent/CN1413206A/en active Pending
- 2000-12-21 CA CA002399584A patent/CA2399584A1/en not_active Abandoned
- 2000-12-21 AU AU23708/01A patent/AU2370801A/en not_active Abandoned
- 2000-12-21 KR KR1020027008007A patent/KR20020062364A/en not_active Application Discontinuation
- 2000-12-21 AP APAP/P/2002/002556A patent/AP2002002556A0/en unknown
- 2000-12-21 PL PL00357650A patent/PL357650A1/en not_active Application Discontinuation
- 2000-12-21 IL IL15020300A patent/IL150203A0/en unknown
-
2002
- 2002-05-24 IS IS6395A patent/IS6395A/en unknown
- 2002-06-10 BG BG106804A patent/BG106804A/en unknown
- 2002-06-14 MA MA26689A patent/MA26854A1/en unknown
- 2002-06-19 NO NO20022942A patent/NO20022942L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001046176A2 (en) | 2001-06-28 |
| EP1244653A1 (en) | 2002-10-02 |
| OA12129A (en) | 2006-05-05 |
| IS6395A (en) | 2002-05-24 |
| CA2399584A1 (en) | 2001-06-28 |
| BG106804A (en) | 2003-03-31 |
| NO20022942D0 (en) | 2002-06-19 |
| NO20022942L (en) | 2002-06-19 |
| PL357650A1 (en) | 2004-07-26 |
| CN1413206A (en) | 2003-04-23 |
| MXPA02006282A (en) | 2004-09-06 |
| IL150203A0 (en) | 2002-12-01 |
| AP2002002556A0 (en) | 2002-06-30 |
| AU2370801A (en) | 2001-07-03 |
| BR0016626A (en) | 2002-11-05 |
| KR20020062364A (en) | 2002-07-25 |
| SK8862002A3 (en) | 2002-11-06 |
| WO2001046176A3 (en) | 2002-07-04 |
| JP2003518111A (en) | 2003-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2010003I1 (en) | BETA-2 ADRENOREGIC RECEPTOR ANTAGONISTS | |
| DE69921351D1 (en) | 4-AROYL-PIPERIDINE-CCR-3 RECEPTOR ANTAGONISTS III | |
| DE69812096T2 (en) | NEUROPEPTID Y RECEPTOR ANTAGONISTS | |
| IS5706A (en) | Adenosine A3 receptor antagonists | |
| DE60026169D1 (en) | SELECTIVE NEUROKININE ANTAGONISTS | |
| NO20015779L (en) | Bradykinin receptor antagonists | |
| DE69919171D1 (en) | MUSCARINE RECEPTOR ANTAGONISTS | |
| ID24726A (en) | TROMBIN RECEPTOR ANTAGONISTS | |
| NO20004503D0 (en) | Vitronectin receptor antagonists | |
| NO20013997L (en) | Receptor | |
| NO20016053D0 (en) | IL-8 receptor antagonists | |
| ID24162A (en) | VITRONECTTIN RECEPTOR ANTAGONISTS | |
| NO20016052L (en) | IL-8 receptor antagonists | |
| PT1146874E (en) | VITRONECTIN RECEPTOR ANTAGONIST | |
| DK1180028T3 (en) | IL-8 receptor antagonists | |
| ATE264301T1 (en) | MUSCARINE ANTAGONISTS | |
| PT1218005E (en) | VITRONECTIN RECEPTOR ANTAGONISTS | |
| NO20015774L (en) | IL-8 receptor antagonists | |
| NO20021295D0 (en) | Nikotinsyreacetylcholin receptor | |
| NO20010620D0 (en) | Vitronectin receptor antagonists | |
| MA26854A1 (en) | NON-PEPTIDE TACHYKININE RECEPTOR ANTAGONISTS | |
| NO20016065L (en) | IL-8 receptor antagonists | |
| NO20016102D0 (en) | IL-8 receptor antagonists | |
| SE0003996D0 (en) | receptor Antagonists | |
| DK1218005T3 (en) | Vitronectin receptor antagonists |